Stockreport

NeOnc Technologies Reports Updated Clinical Results [Yahoo! Finance]

NeOnc Technologies Holdings, Inc.  (NTHI) 
PDF and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- [Read more]